“…Lee et al 9 nicely demonstrate that when a patient does get listed for cardiac transplantation, it is important to have a discussion with the patient regarding their hormone replacement therapy and that the patient should understand that the dosage or formulation can be modified or even temporarily held during the intraoperative period. The interaction of hormone therapy and immunosuppressive medications is stressed, as is the need to closely monitor tacrolimus levels.…”